NOVONORM cpr 0.5 mg 90 pce
7680545710119
CH-54571
A10BX02
07.06.2.
1 / 3
google
Details
- Product number
- 5457101
- CPT
- -
- Packaging group
- 90
- Unit
- Tablette(n)
- Composition
- repaglinidum 0.5 mg, poloxamerum 188, povidonum K 25, megluminum, maydis amylum, calcii hydrogenophosphas, cellulosum microcristallinum, glycerolum (85 per centum), polacrilinum kalicum, magnesii stearas pro compresso.
Articles (1)
NovoNorm 0,5 mg, Tabletten
Tabletten
90
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
repaglinidum
|
0.5 MG | Substance | Wirkstoff (Principe actif) |
|
poloxamerum 188
|
- | Substance | HNIDK |
|
povidonum K 25
|
- | Substance | HNIDK |
|
megluminum
|
- | Substance | HNIDK |
|
maydis amylum
|
- | Substance | HNIDK |
|
calcii hydrogenophosphas
|
- | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
glycerolum (85 per centum)
|
- | Substance | HBESI |
|
polacrilinum kalicum
|
- | Substance | HNIDK |
|
magnesii stearas
|
- | Substance | HNIDK |
Authorization holder
Novo Nordisk Pharma AG
8302 Kloten
Authorization information
- Swissmedic authorization number
- 54571
- Drug name
- NovoNorm, Tabletten
- Galenic form
- TAB
- ATC Code
- A10BX02
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 28/09/1999
- Authorization expiration date
- 31/03/2026
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- NOVONORM cpr 0.5 mg 90 pce
- Description (DE)
- NOVONORM Tabl 0.5 mg 90 Stk
- Market launch
- 28/09/1999
- Market withdrawal
- 31/03/2026
- Narcotic (BTM)
- No